According to our understanding, an apoptotic prognostic model of BC patients was identified and verified for the first time in our study, which contains two apoptotic genes (IL3RA and AIFM1) and can be used as an independent prognostic marker for BC patients. The gene discussed is IL3RA; the disease is breast cancer.